Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
NCT ID: NCT06723041
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
78 participants
INTERVENTIONAL
2024-12-11
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To test the efficacy of a nurse-applied acupressure intervention for anxiety associated with active cancer-directed therapy.
SECONDARY OBJECTIVES:
I. To test the efficacy of a patient-applied acupressure intervention for anxiety associated with active cancer-directed therapy.
II. To assess whether acupressure appears to improve nausea related to cancer and cancer-directed therapy.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients undergo true acupressure over 10 minutes on study. Patients that choose to learn self-administration acupressure at home receive educational information and undergo self-administration acupressure sessions at least twice daily (BID) for seven days.
ARM II: Patients undergo sham acupressure over 10 minutes on study. Patients that choose to learn self-administration acupressure at home receive educational information and undergo self-administration acupressure sessions at least BID for seven days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (true acupressure)
Patients undergo true acupressure over 10 minutes on study. Patients that choose to learn self-administration acupressure at home receive educational information and undergo self-administration acupressure sessions at least BID for seven days.
Acupressure Therapy
Undergo true acupressure
Acupressure Therapy - self-administered
Undergo self-administered acupressure
Health Promotion and Education
Receive educational handouts
Survey Administration
Ancillary studies
Arm II (sham acupressure)
Patients undergo sham acupressure over 10 minutes on study. Patients that choose to learn self-administration acupressure at home receive educational information and undergo self-administration acupressure sessions at least BID for seven days.
Acupressure Therapy - placebo
Undergo sham acupressure
Acupressure Therapy - self-administered
Undergo self-administered acupressure
Health Promotion and Education
Receive educational handouts
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupressure Therapy
Undergo true acupressure
Acupressure Therapy - placebo
Undergo sham acupressure
Acupressure Therapy - self-administered
Undergo self-administered acupressure
Health Promotion and Education
Receive educational handouts
Survey Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* NURSE-LED INTERVENTION: Undergoing systemic, antineoplastic therapy
* NURSE-LED INTERVENTION: Ability to provide oral consent
* NURSE-LED INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
* NURSE-LED INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
* NURSE-LED INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)
* SELF-ADMINISTRATION INTERVENTION: Age \>= 18 years and be diagnosed with cancer
* SELF-ADMINISTRATION INTERVENTION: Undergoing systemic, antineoplastic therapy
* SELF-ADMINISTRATION INTERVENTION: Ability to provide oral consent
* SELF-ADMINISTRATION INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
* SELF-ADMINISTRATION INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
* SELF-ADMINISTRATION INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)
* SELF-ADMINISTRATION INTERVENTION: Reports 2+/day anxiety episodes at home
* SELF-ADMINISTRATION INTERVENTION: Interested in learning self-administered acupressure
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Cathcart-Rake, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Clinical Trials Referral Office
Role: primary
Jennifer Manggaard
Role: backup
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-09813
Identifier Type: REGISTRY
Identifier Source: secondary_id
24-007105
Identifier Type: OTHER
Identifier Source: secondary_id
24-007105
Identifier Type: -
Identifier Source: org_study_id